Advertisement
Screener

BiomX Inc. (PHGE) Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount

BiomX Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount

BiomX Inc. (PHGE) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount of $3.74 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-30.

Discontinued › Expense Statement › Income Tax

us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment · last filed 2022-03-30

  • BiomX Inc. effective income tax rate reconciliation, nondeductible expense, research and development, amount for fiscal 2021 was $3.74M, a 622.20% increase from fiscal 2020.
  • BiomX Inc. effective income tax rate reconciliation, nondeductible expense, research and development, amount for fiscal 2020 was $518.00K.
Period endEffective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount 12 month
2021-12-31$3.74M
10-K · filed 2022-03-30
2020-12-31$518.00K
10-K · filed 2022-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Intellicheck, Inc. (IDN)United States$0.049B26.37
PIXELWORKS, INC (PXLW)United States$0.044B
Aether Holdings, Inc. (ATHR)United States$0.043B-11.40
Where Food Comes From, Inc. (WFCF)United States$0.055B
Skillsoft Corp. (SKIL)United States$0.056B-0.39
NETSOL TECHNOLOGIES INC (NTWK)United States$0.056B23.14
Advasa Holdings, Inc. (ADBT)$0.060B
Airship AI Holdings, Inc. (AISP)United States$0.065B3.15
Sports Entertainment Gaming Global Corp (SEGG)United States$0.066B-0.25
Great Elm Group, Inc. (GEG)United States$0.067B-1.76